Evaluation of Accuvein in Obese Patients

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02015845

Acronym

AVO

Enrollment

Registered

2013-12-19

Start date

2013-11-30

Completion date

2017-05-31

Last updated

2017-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Care

Brief summary

The objective of this study is to evaluate the effectiveness of Accuvein to facilitate placement of peripheral intravenous catheters in obese patients. This clinical protocol is designed to determine whether using Accuvein increases the ease and efficiency of venous cannulation (as perceived by the operator), decreases the time to effective cannulation, and decreases the patient's perception of the pain.

Interventions

DEVICEAccuvein

DEVICERoutine technique

Placement of peripheral intravenous catheters using the routine technique

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* obese adults ( BMI equal or greater 35) requiring a venous blood sampling or the placement of a venous peripheral catheter

Exclusion criteria

* pregnant woman

Design outcomes

Primary

Measure	Time frame	Description
Percentage of success of the first vein puncture	one hour	Successful successful placement of IV catheter

Secondary

Measure	Time frame	Description
Score of evaluation of the device	one hour	Evaluation of the device by the operator and the patient

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026